JOP20200165A1 - عمليات ووسائط جديدة لتحضير محفزات إنزيم حلقي جوانيلات قابلة للذوبان - Google Patents

عمليات ووسائط جديدة لتحضير محفزات إنزيم حلقي جوانيلات قابلة للذوبان

Info

Publication number
JOP20200165A1
JOP20200165A1 JOP/2020/0165A JOP20200165A JOP20200165A1 JO P20200165 A1 JOP20200165 A1 JO P20200165A1 JO P20200165 A JOP20200165 A JO P20200165A JO P20200165 A1 JOP20200165 A1 JO P20200165A1
Authority
JO
Jordan
Prior art keywords
guanylate
catalysts
media
new processes
preparing soluble
Prior art date
Application number
JOP/2020/0165A
Other languages
Arabic (ar)
English (en)
Inventor
Ahmad Hashash
Song Xue
Takashi Nakai
Debra Jane Wallace
Yuguang Wang
William Kissel
Wayne C Schairer
Fenger Zhou
Vishnu Vardhan Reddy Karnati
Original Assignee
Cyclerion Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/CN2018/076982 external-priority patent/WO2019161534A1/en
Application filed by Cyclerion Therapeutics Inc filed Critical Cyclerion Therapeutics Inc
Publication of JOP20200165A1 publication Critical patent/JOP20200165A1/ar

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C237/06—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C237/08—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235—Saturated compounds containing more than one carboxyl group
    • C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
JOP/2020/0165A 2018-01-10 2019-01-10 عمليات ووسائط جديدة لتحضير محفزات إنزيم حلقي جوانيلات قابلة للذوبان JOP20200165A1 (ar)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862615678P 2018-01-10 2018-01-10
PCT/CN2018/076982 WO2019161534A1 (en) 2018-02-22 2018-02-22 Novel processes and intermediates for preparation of soluble guanylate cyclase stimulators
PCT/US2019/013060 WO2019140095A1 (en) 2018-01-10 2019-01-10 Novel processes and intermediates for the preparation of soluble guanylate cyclase stimulators

Publications (1)

Publication Number Publication Date
JOP20200165A1 true JOP20200165A1 (ar) 2022-10-30

Family

ID=65279655

Family Applications (1)

Application Number Title Priority Date Filing Date
JOP/2020/0165A JOP20200165A1 (ar) 2018-01-10 2019-01-10 عمليات ووسائط جديدة لتحضير محفزات إنزيم حلقي جوانيلات قابلة للذوبان

Country Status (16)

Country Link
US (5) US11274096B2 (enExample)
EP (3) EP4249469A3 (enExample)
JP (2) JP7357621B2 (enExample)
KR (3) KR102739727B1 (enExample)
CN (3) CN111902410B (enExample)
AU (3) AU2019206560B2 (enExample)
CA (1) CA3087943A1 (enExample)
CL (3) CL2020001814A1 (enExample)
ES (1) ES2963447T3 (enExample)
IL (3) IL275748B2 (enExample)
JO (1) JOP20200165A1 (enExample)
MA (2) MA71753A (enExample)
MX (3) MX2020007364A (enExample)
SG (1) SG11202006311SA (enExample)
TW (2) TWI821237B (enExample)
WO (1) WO2019140095A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102487872B1 (ko) 2016-07-07 2023-01-12 사이클리온 테라퓨틱스, 인크. 가용성 구아닐레이트 시클라제 자극제의 신규 제조 방법
CN111902410B (zh) 2018-01-10 2024-04-19 赛克里翁治疗有限公司 用于制备可溶性鸟苷酸环化酶刺激剂的方法及中间物
CN118221651A (zh) * 2022-12-21 2024-06-21 广东东阳光药业股份有限公司 氟取代的吲唑化合物的晶型及其用途
AU2023412228A1 (en) * 2022-12-21 2025-07-03 Sunshine Lake Pharma Co., Ltd. Crystal form of fluorine-substituted indazole compound and use thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI532737B (zh) * 2010-06-30 2016-05-11 艾諾屋製藥公司 可溶性鳥苷酸環化酶(sGC)刺激物
ES2911276T3 (es) * 2013-03-15 2022-05-18 Cyclerion Therapeutics Inc Estimuladores de sGC
WO2015106268A1 (en) * 2014-01-13 2015-07-16 Ironwood Pharmaceuticals, Inc. USE OF sGC STIMULATORS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS
CN107223125B (zh) * 2014-09-17 2019-09-27 赛科理音医疗有限公司 sGC刺激剂
EP3194382B1 (en) 2014-09-17 2021-09-08 Cyclerion Therapeutics, Inc. Pyrazole derivatives as sgc stimulators
BR112018011154B1 (pt) * 2015-11-30 2023-09-26 Cyclerion Therapeutics, Inc Dispersões sólidas compreendendo um estimulador de sgc
EA201990236A1 (ru) 2016-07-07 2019-08-30 Сайклерион Терапьютикс, Инк. Новые способы получения стимуляторов растворимой гуанилатциклазы
KR102487872B1 (ko) 2016-07-07 2023-01-12 사이클리온 테라퓨틱스, 인크. 가용성 구아닐레이트 시클라제 자극제의 신규 제조 방법
CN111902410B (zh) 2018-01-10 2024-04-19 赛克里翁治疗有限公司 用于制备可溶性鸟苷酸环化酶刺激剂的方法及中间物

Also Published As

Publication number Publication date
TWI888947B (zh) 2025-07-01
CL2020001814A1 (es) 2020-11-06
US20230339928A1 (en) 2023-10-26
MA71753A (fr) 2025-05-30
US11708361B2 (en) 2023-07-25
US11274096B2 (en) 2022-03-15
ES2963447T3 (es) 2024-03-27
KR20250002720A (ko) 2025-01-07
US20250361228A1 (en) 2025-11-27
KR102739727B1 (ko) 2024-12-05
CA3087943A1 (en) 2019-07-18
CN118184645A (zh) 2024-06-14
MX2020007364A (es) 2020-11-18
IL319883A (en) 2025-05-01
JP7357621B2 (ja) 2023-10-06
JP2023182647A (ja) 2023-12-26
MX2023000044A (es) 2023-02-01
EP3737679A1 (en) 2020-11-18
EP4249469A3 (en) 2023-12-27
MX2023000045A (es) 2023-02-01
US20210053962A1 (en) 2021-02-25
WO2019140095A1 (en) 2019-07-18
KR20200106920A (ko) 2020-09-15
AU2019206560A1 (en) 2020-07-30
EP4249469A2 (en) 2023-09-27
CN111902410A (zh) 2020-11-06
CN111902410B (zh) 2024-04-19
EP3737679B1 (en) 2023-09-06
IL275748A (en) 2020-08-31
EP4570797A2 (en) 2025-06-18
AU2025202281A9 (en) 2025-05-15
IL314714A (en) 2024-10-01
AU2019206560B2 (en) 2023-08-24
US12275724B2 (en) 2025-04-15
CL2022000904A1 (es) 2022-10-21
US20240391911A1 (en) 2024-11-28
TWI821237B (zh) 2023-11-11
BR112020013985A2 (pt) 2020-12-01
AU2023270260B2 (en) 2026-01-29
WO2019140095A8 (en) 2020-06-18
JP2021511299A (ja) 2021-05-06
US12030874B2 (en) 2024-07-09
CN118221665A (zh) 2024-06-21
MA51565A (fr) 2020-11-18
AU2023270260A1 (en) 2023-12-07
SG11202006311SA (en) 2020-07-29
KR20250048609A (ko) 2025-04-09
TW201932450A (zh) 2019-08-16
EP3737679C0 (en) 2023-09-06
JP7744955B2 (ja) 2025-09-26
AU2025202281A1 (en) 2025-04-17
TW202402741A (zh) 2024-01-16
EP4570797A3 (en) 2025-09-03
US20220024909A1 (en) 2022-01-27
CL2022000907A1 (es) 2022-10-21
IL314714B1 (en) 2026-06-01
IL275748B2 (en) 2025-01-01
IL275748B1 (en) 2024-09-01

Similar Documents

Publication Publication Date Title
IL282084A (en) Optimized truss foundations, adapters for optimized truss foundations, and related systems and methods
CL2019001554S1 (es) Automóvil.
EP3758293A4 (en) PROCEDURE, DEVICE, AND STORAGE MEDIUM FOR SERVICE UPGRADE
MX2021006237A (es) Anticuerpos anti-tigit, anticuerpos anti-pvrig y combinaciones de estos.
CL2020000174S1 (es) Automóvil.
CL2018000947S1 (es) Automóvil
EP3689057A4 (en) PROCESS, DEVICE AND MEDIA READABLE INFORMATION BY RADIO PASSENGER
MX2020002831A (es) Metodos y procesos para evaluacion no invasiva de variaciones geneticas.
MX2017007049A (es) Anticuerpos anti-cd79b y métodos de uso.
CR20160500A (es) Anticuerpos anti-ox40 y métodos de uso
MX2024011869A (es) Anticuerpos anti-tau y metodos de uso
MX2017015464A (es) Anticuerpos anti-tau y metodos de uso.
MX374788B (es) Anticuerpos anti-tim3 y metodos de uso.
CL2018001940S1 (es) Automóvil
CR20190271A (es) Anticuerpos antitau y métodos de uso
MX2016010433A (es) Anticuerpos anti-jagged1 y metodos de uso.
MX2017001981A (es) Inhibidores de diana de rapamicina en celulas de mamifero de complejo 1 (mtorc1).
CL2016002667A1 (es) Anticuerpos anti-rnf43 novedosos y métodos para su uso
EP3779516C0 (en) POSITIONING SYSTEM, BASE STATION AND POSITIONING METHOD
CL2019002232S1 (es) Automóvil.
CL2020001201S1 (es) Automóvil.
JOP20200244B1 (ar) مشتقات بلاديينوليد كعوامل تستهدف جسيمات الوصل لعلاج السرطان
CL2018000791S1 (es) Automóvil
JOP20210036A1 (ar) مثبطات او- جليكوبروتين-2-أسيتاميدو-2-ديوكسي-3-دي-جلوكوبيرانوسيداز
EP3685603A4 (en) HANDS-FREE INTERACTION SYSTEM AND METHOD